| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Langner FW, Kemp MD |
LSD 25 |
Quart. Bull. Pineblu... |
1956 |
| Elder JT, Shellenberger M... |
Antagonism of lysergic acid diethylamide (LSD)-induced hyperthermia |
J. Pharmacol. exp. T... |
1962 |
| Shellard EJ, Lees MD |
The Mitragyna species of AsiaVThe anatomy of the leaves of Mitragyna s... |
Planta Med |
1965 |
| Fremont-Smith F, Altschul... |
Pros and con regarding LSD. (Letters to the Editor) |
New Engl. J. Med. |
1966 |
| Fairchild MD, Alles GA, J... |
The effects of mescaline, amphetamine and four-ring substituted amphet... |
Int J Neuropharmacol |
1967 |
| Lerner M, Katsiaficas MD |
Analytical separations of mixtures of hallucinogenic drugs |
Bull. Narcot. |
1969 |
| Shellard E J, Walker MD |
The Mitragyna species of Asia. XVI. The morphology and anatomy of the ... |
Planta Med |
1969 |
| Schechter MD, Winter JC |
Effect of mescaline and lysergic acid diethylamide on flicker discrimi... |
J. Pharmacol. Exp. T... |
1971 |
| Hester JB, Rudzik AD, Kam... |
6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines which have central n... |
J Med Chem |
1971 |
| Stanton MD, Bardoni A |
Drug Flashbacks: Reported Frequency in a Mililtary Population |
Am J Psychiatry |
1972 |
| Schechter MD, Winter JC |
Effect of BOL on the LSD-induced alteration of flicker discrimination ... |
Arch. int. Pharmocod... |
1972 |
| Schechter MD, Rosecrans J... |
Lysergic acid diethylamide (LSD) as a discriminative cue: drugs with s... |
Psychopharmacologia |
1972 |
| Stanton MD, Bardoni A |
Drug flashbacks: reported frequency in a military population |
Amer. J. Psychiat. |
1972 |
| Schechter MD, Rosecrans J... |
D-amphetamine as a discriminative cue: drugs with similar stimulus pro... |
Europ. J. Pharmacol. |
1973 |
| Stanton MD |
Dr Stanton Replies |
Amer J Psychiat |
1973 |
| Stanton MD |
Drugs, Vietnam, and the Vietnam veteran: an overview |
Am J Drug Alcohol Ab... |
1976 |
| Gershon MD, Robinson RG, ... |
Serotonin Accumulation in the Guinea-Pig Myenteric Plexus: Ion Depende... |
J.Pharmacol.Exp.Ther... |
1976 |
| Greenblatt DJ, Allen MD, ... |
Accidental Poisoning with Psychotropic Drugs in Children. |
Am.J.Dis.Child. |
1976 |
| Stanton MD, Mintz J, Fran... |
Drug Flashbacks. II. Some Additional Findings |
Int. J. Addict. |
1976 |
| Walters JR, Baring MD, La... |
Effects of ergolines on dopaminergic and serotonergic single unit acti... |
Dopaminergic Ergot D... |
1979 |
| Fairchild MD, Jenden DJ, ... |
EEG Effects of Hallucinogens and Cannabinoids Using Sleep-Waking Behav... |
Pharmacol. Biochem. ... |
1980 |
| Wlikison DM, Hosko MD |
The Pharmacologist |
|
1982 |
| Hoffman BJ, Karpa MD, Lev... |
N1-Methyl-2-|125|LSD(|128|)MIL), A Preferrred Ligand for Serotonin 5-H... |
European Journal of ... |
1985 |
| Schechter MD |
Discriminative profile of MDMA |
Pharmacol Biochem Be... |
1986 |
| Boja JW, Schechter MD |
Behavioral effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE; 'EVE... |
Pharmacol Biochem Be... |
1987 |
| Kulmala HK, Boja JW, Sche... |
Behavioral suppression following 3,4-methylenenedioxymethamphetamine |
Life Sci |
1987 |
| Schechter MD |
MDMA as a discriminative stimulus: isomeric comparisons |
Pharmacol Biochem Be... |
1987 |
| Mathews JD, Riley MD, Fej... |
Effects of the heavy usage of kava on physical health: summary of a pi... |
Med J Aust |
1988 |
| Schechter MD |
Use of TFMPP stimulus properties as a model of 5-HT1B receptor activat... |
Pharmacol Biochem Be... |
1988 |
| Schechter MD |
Advantages and disadvantages of a rapid method to train drug discrimin... |
Pharmacol Biochem Be... |
1988 |
| Schechter MD |
Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetami... |
Pharmacol Biochem Be... |
1989 |
| Crisp T, Stafinsky JL, Bo... |
The antinociceptive effects of 3,4-methylenedioxymethamphetamine (MDMA... |
Pharmacol Biochem Be... |
1989 |
| Kelland MD, Freeman AS, C... |
(+/-)-3,4-Methylenedioxymethamphetamine-induced changes in the basal a... |
Eur J Pharmacol |
1989 |
| Herkenham M, Lynn AB, Lit... |
Cannabinoid receptor localization in brain |
Proc Natl Acad Sci U... |
1990 |
| Bhattacharyya BJ, Sokoll ... |
Effect of +/--DOI on neuromuscular transmission: a microelectrode stud... |
Eur J Pharmacol |
1991 |
| Schechter MD |
Effect of MDMA neurotoxicity upon its conditioned place preference and... |
Pharmacol Biochem Be... |
1991 |
| Schechter MD |
Effect of serotonin depletion by p-chlorophenylalanine upon discrimina... |
Gen Pharmacol |
1991 |
| Boja JW, Schechter MD |
Possible serotonergic and dopaminergic mediation of the N-ethyl-3,4-me... |
Eur J Pharmacol |
1991 |
| Schechter MD, Gordon TL |
Comparison of the behavioral effects of ibogaine from three sources: m... |
Eur J Pharmacol |
1993 |
| Merlin MD, Allen JW |
Species identification and chemical analysis of psychoactive fungi in ... |
J Ethnopharmacol |
1993 |
| Cornelius MD, Taylor PM, ... |
Prenatal tobacco and marijuana use among adolescents: effects on offsp... |
Pediatrics |
1995 |
| Meehan SM, Gordon TL, Sch... |
MDMA (Ecstasy) substitutes for the ethanol discriminative cue in HAD b... |
Alcohol |
1995 |
| Reid LD, Hubbell CL, Tsai... |
Naltrindole, a delta-opioid antagonist, blocks MDMA's ability to enhan... |
Pharmacol Biochem Be... |
1995 |
| Reid LD, Hubbell CL, Tsai... |
Naltrindole, a delta-opioid antagonist, blocks MDMA's ability to enhan... |
Pharmacol Biochem Be... |
1996 |
| Schechter MD |
Drug-drug discrimination: stimulus properties of drugs of abuse upon a... |
Pharmacol Biochem Be... |
1997 |
| Schechter MD |
Discrete versus cumulative dosing in dose-response discrimination stud... |
Eur J Pharmacol |
1997 |
| Schechter MD |
Serotonergic mediation of fenfluramine discriminative stimuli in fawn-... |
Life Sci |
1997 |
| Mathews JD, Riley MD, Fej... |
Effects of the heavy usage of kava on physical health: summary of a pi... |
Med J Aust |
1998 |
| Schechter MD |
'Candyflipping': synergistic discriminative effect of LSD and MDMA |
Eur J Pharmacol |
1998 |
| Schechter MD |
MDMA-like stimulus effects of hallucinogens in male Fawn-Hooded rats |
Pharmacol Biochem Be... |
1998 |
| Schechter MD |
MDMA-like stimulus effects of hallucinogens in male Fawn-Hooded rats |
Pharmacol Biochem Be... |
1998 |
| Mash DC, Kovera CA, Buck ... |
Medication development of ibogaine as a pharmacotherapy for drug depen... |
Ann N Y Acad Sci |
1998 |
| Mann JJ, Huang YY, Underw... |
A serotonin transporter gene promoter polymorphism (5-HTTLPR) and pref... |
Arch Gen Psychiatry |
2000 |
| Roth MD, Marques-Magallan... |
Induction and regulation of the carcinogen-metabolizing enzyme CYP1A1 ... |
Am J Respir Cell Mol... |
2001 |
| Tossmann P, Boldt S, Tens... |
The use of drugs within the techno party scene in European metropolita... |
Eur Addiction Res |
2001 |
| McCann UD, Ricaurte GA, M... |
'Ecstasy' and serotonin neurotoxicity: New findings raise more questio... |
Archives of General ... |
2001 |
| Carmo H, de Boer D, Remiã... |
Identification of 4-methylthioamphetamine and some of its metabolites ... |
J Anal Toxicol |
2002 |
| Saldana MD, Zetzl C, Moha... |
Extraction of methylxanthines from guaraná seeds, maté leaves, and c... |
J Agric Food Chem |
2002 |
| Cole MD |
The Analysis of LSD |
The Analysis of Cont... |
2003 |
| Drummer OH, Gerostamoulos... |
The incidence of drugs in drivers killed in Australian road traffic cr... |
Forensic Sci Int |
2003 |
| Doering-Silveira E, Grob ... |
Report on psychoactive drug use among adolescents using ayahuasca with... |
J Psychoactive Drugs |
2005 |
| de Rios MD, Grob CS, Lope... |
Ayahuasca in adolescence: Qualitative results |
J Psychoactive Drugs |
2005 |
| Da Silveira DX, Grob CS, ... |
Ayahuasca in adolescence: a preliminary psychiatric assessment |
J Psychoactive Drugs |
2005 |
| Doering-Silveira E, Lopez... |
Ayahuasca in adolescence: a neuropsychological assessment |
J Psychoactive Drugs |
2005 |
| Schmidt MD, Schmidt MS, B... |
Pharmacokinetics of the plant-derived kappa-opioid hallucinogen salvin... |
Synapse |
2005 |
| Wilson MD, Ferguson RW, M... |
Monitoring trends in dextromethorphan abuse using the National Poison ... |
Clinical Toxicology |
2011 |
| Dos Santos RG, Valle M, B... |
Autonomic, Neuroendocrine, and Immunological Effects of Ayahuasca: A C... |
J Clin Psychopharmac... |
2011 |
| Arbo MD, Bastos ML, Carmo... |
Piperazine compounds as drugs of abuse |
Drug Alcohol Depend |
2011 |
| Dybdal-Hargreaves NF, Hol... |
Mephedrone: Public health risk, mechanisms of action, and behavioral e... |
Eur J Pharmacol |
2013 |
| Borah A, Paul R, Mazumder... |
Contribution of β-phenethylamine, a component of chocolate and wi... |
Neurosci Bull |
2013 |
| Pineli Lde L, Rodrigues J... |
Antioxidants and sensory properties of the infusions of wild passiflor... |
J Sci Food Agric |
2015 |
| Araújo AM, Carvalho F, Ba... |
The hallucinogenic world of tryptamines: an updated review |
Arch Toxicol |
2015 |
| Stein MD, Risi MM, Bailey... |
Linkage to Primary Care for Persons First Receiving Injectable Naltrex... |
J Subst Abuse Treat |
2016 |
| Kruegel AC, Gassaway MM, ... |
Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloi... |
J Am Chem Soc |
2016 |
| Xi-Ping Huang, Che T, Man... |
Pharmacology OF W-18 AND W-15 |
bioRxiv |
2016 |
| Lozano-Torres B, Pascual ... |
Pseudorotaxane capped mesoporous silica nanoparticles for 3,4-methylen... |
Chem Commun (Camb) |
2017 |
| Meader N, Mdege N, McCamb... |
The public health evidence-base on novel psychoactive substance use: s... |
J Public Health (Oxf... |
2018 |
| Nicholas B.GiancolaBAClay... |
A “trip” to the ICU: intravenous injection of psilocybin |
Journal of the Acade... |
2021 |
